Professor, Medicine, University of Alabama School of Medicine
Nephrology
Dr. Roslyn B. Mannon, MD
|
|
Give Review
Roslyn B. Mannon, MD practices Nephrology. She studied medicine at Duke University School of Medicine. Duke University School of Medicine is a top medical university. Duke University School of Medicine is ranked 8 in research and 29 in primary care medicine She over the years received 4 awards: "Fellow", "Regional Top Doctor", "President" and "Fellow (ASNF)". Roslyn B. Mannon is a published physician. She published 97 publications, including: 'Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2.' She is registered with Medicare and accepts Medicare payments.
Publications
- Hospital-Onset Clostridium difficile Infection Among Solid Organ Transplant Recipients.
- Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles.
- Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients.
- Identification of strategies to facilitate organ donation among African Americans using the nominal group technique.
- Genomic and proteomic fingerprints of Acute rejection in peripheral blood and urine.
- Cyclosporine-mediated allograft fibrosis is associated With micro-rna 21 through akt signaling.
- The prognostic value of left ventricular mechanical dyssynchrony using gated myocardial perfusion imaging in patients With end-stage renal disease.
- Necroptosis in solid organ transplantation: a missing link to Immune activation?
- Immunosuppression Regimen and the Risk of Acute Rejection in HIV-Infected Kidney Transplant Recipients.
- Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling.
- A reproducible mouse model of Chronic allograft nephropathy with vasculopathy.
- A Case of Late Kidney Allograft Failure: A Clinical Pathological Conference from American Society of Nephrology Kidney Week 2011.
- Associations of ABCB1 3435C>T and IL-10-1082G>A Polymorphisms With Long-Term Sirolimus Dose Requirements in Renal Transplant Patients.
- Macrophages: contributors to allograft dysfunction, repair, or innocent bystanders?
- Chemokines and their receptors in human Renal allotransplantation.
- Immune monitoring and biomarkers to predict Chronic allograft dysfunction.
- Optimal cutoff point for immunoperoxidase detection of C4d in the Renal allograft: results from a multicenter study.
- Probabilistic (Bayesian) modeling of gene expression in transplant glomerulopathy.
- Noninvasive methods to assess the risk of Kidney transplant rejection.
- C3 polymorphisms and outcomes of Renal allografts.
- Leflunomide therapy in Kidney transplantation: ready for prime time?
- Therapeutic management of posttransplant Diabetes mellitus.
- Care of the Kidney transplant recipient.
- Late Kidney allograft loss: what we know about it, and what we can do about it.
- Diagnostic tools for monitoring Kidney transplant recipients.
- Immunodiagnostics: evaluation of functional T-cell immunocompetence in whole blood independent of circulating cell numbers.
- Assessing relative risks of infection and rejection: a meta-analysis using an Immune function assay.
- Beyond histology: novel tools to diagnose allograft dysfunction.
- Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154.
- Results from a human renal allograft tolerance trial evaluating T-cell depletion With alemtuzumab combined With deoxyspergualin.
- Detection and localization of Proteinuria by dynamic contrast-enhanced magnetic resonance imaging using MS325.
- Surgical transplant physical examination: correlation of renal resistance index and biopsy-proven Chronic allograft nephropathy.
- Solid organ transplantation at the National Institutes of Health: development of a research-based transplantation practice.
- Polyomavirus Nephropathy: what have we learned?
- Results from a human Renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).
- Delayed autotransplantation of a solitary Kidney facilitated by pump perfusion preservation.
- BK virus and SV40 co-Infection in polyomavirus nephropathy.
- Molecular and immunohistochemical characterization of the onset and resolution of human Renal allograft ischemia-reperfusion injury.
- Absence of donor MHC antigen expression ameliorates chronic Kidney allograft rejection.
- What's New, What's Hot in Solid Organ Transplantation? Summary of the American Transplant Congress 2011.
- Pharmacokinetics of low and maintenance dose valganciclovir in Kidney transplant recipients.
- Banff 07 classification of Renal allograft pathology: updates and future directions.
- Monocyte infiltration and kidney allograft dysfunction during Acute rejection.
- Connective tissue growth factor is a biomarker and mediator of Kidney allograft fibrosis.
- Autoimmune thyroid disease after renal transplantation using depletional induction With alemtuzumab.
- Therapeutic targets in the treatment of allograft fibrosis.
- Successful renal transplantation in patients with Chronic granulomatous disease.
- Molecular evaluation of BK polyomavirus Nephropathy.
- Allograft fibrosis--unmasking the players at the dance.
- Inflammation in areas of tubular atrophy in Kidney allograft biopsies: a potent predictor of allograft failure.
- Cinacalcet improves bone density in post-Kidney transplant hyperparathyroidism.
- Banff ''05 Meeting Report: differential diagnosis of Chronic allograft injury and elimination of Chronic allograft nephropathy (''CAN'').
- Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.
- Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse Kidney allografts.
- Stimulation of thymocyte proliferation by phosphorothioate DNA oligonucleotides.
- Enhanced T cell cytokine gene expression in mouse airway obliterative bronchiolitis.
- Angiotensin II regulates cellular Immune responses through a calcineurin-dependent pathway.
- Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection.
- Peptide YY/neuropeptide Y Y1 receptor expression in the epithelium and mucosal nerves of the human colon.
- Gene targeting: applications in transplantation research.
- Chronic rejection of mouse Kidney allografts.
- Coagulation defects and altered hemodynamic Responses in mice lacking receptors for thromboxane A2.
- Immune cells in a mouse airway model of obliterative bronchiolitis.
- Thromboxane A2 modulates the fibrinolytic system in glomerular mesangial cells.
- Downregulation of T cell receptor expression by CD8(+) lymphocytes in Kidney allografts.
- Distribution of binding sites for thromboxane A2 in the mouse Kidney.
- The intragraft CD8+ T cell response in Renal allograft rejection in the mouse.
- Alterations in renal interleukin-1 production during Kidney transplant rejection in the rat. The effects of high-dose methylprednisolone.
- Management of Hypertensive emergencies and urgencies.
- Hyperrenin-hyperaldosterone-dependent malignant Hypertension in polyarteritis nodosa.
- Rejection of Kidney allografts by MHC class I-deficient mice.
- Immunologic mechanisms of transplant rejection.
- Deficiency of 5-lipoxygenase accelerates Renal allograft rejection in mice.
- Receptors for prostaglandin E(2) that regulate cellular Immune responses in the mouse.
- Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study.
- Histopathologic clusters differentiate subgroups Within the nonspecific diagnoses of CAN or CR: preliminary data from the DeKAF study.
- Lack of Renal dopamine D5 receptors promotes hypertension.
- Evidence for antibody-mediated injury as a major determinant of late Kidney allograft failure.
- Donor genomics influence graft events: the effect of donor polymorphisms on Acute rejection and chronic allograft nephropathy.
- Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy.
- The clinical application of monoclonal antibody therapies in Renal transplantation.
- Successful renal transplantation in a patient With congenital generalized lipodystrophy: a case report.
- First NIH/Office of Rare Diseases Conference on Cystinosis: past, present, and future.
- Functionally significant Renal allograft rejection is defined by transcriptional criteria.
- Immunocompetent T-cells With a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion.
- Strategies for minimizing immunosuppression in Kidney transplantation.
- Inhibition of prolyl-4-hydroxylase ameliorates chronic rejection of mouse Kidney allografts.
- The road to tolerance: Renal transplant tolerance induction in nonhuman primate studies and clinical trials.
- Idiopathic intracranial hypertension following Kidney transplantation: a case report and review of the literature.
- Obesity following Kidney transplantation and steroid avoidance immunosuppression.
- Islet transplantation: need for a time-out?
- Lymphocyte depletion for Kidney transplantation: back to the past?
- Evaluation of tacrolimus abbreviated area-under-the-curve monitoring in Renal transplant patients who are potentially at risk for adverse events.
- Low-density array PCR analysis of reperfusion biopsies: an adjunct to histological analysis.
- Elevated expression levels of ANXA11, integrins β3 and α3, and TNF-α contribute to a candidate proteomic signature in urine for Kidney allograft rejection.
- Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation.
Schools
Duke University School Of Medicine
Duke University Med Center
Procedures Preformed
- Hemodialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Calcium Metabolism Disorders
- Chronic Glomerulonephritis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Fellow
- Regional Top Doctor
- President
- Fellow (ASNF)
Education
-
Duke University Hospital -
Duke University School of Medicine
Hospital
-
University of Alabama Hospital -
Birmingham Veterans Affairs Medical Center
Drug Facts
| NPI NUMBER | 1558583377 | |
| NPPES Provider LastName | MANNON | |
| NPPES Provider FirstName | ROSLYN | |
| NPPES Provider ZIPCode | 352332060 | |
| NPPES Provider State | AL | |
| Specialty Description | Nephrology | |
| Total Claim Count | 809.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1558583377 |
| Last Name Of The Provider | MANNON |
| First Name Of The Provider | ROSLYN |
| View All |
Similar Doctors
|
|
Dr. Rahim Kassamali, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nakshatra Saxena, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anupam Agarwal, MD |
|
|
Dr. Sumant Chugh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James C. Harms, MD |
|
|
Sonya L. Praytor, NP |